查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1672124

全球生物銀行市場研究報告 - 產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

Global Biobanking Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格

全球生物銀行市場規模預計將從 2024 年的 38.4 億美元成長到 2033 年的 107.3 億美元，在 2026 年至 2033 年的預測期內，年複合成長率(CAGR) 將達到 12.07%。

隨著研究和臨床應用對生物樣本和資料的需求不斷成長，生物銀行市場有望大幅成長。生物庫透過提供各種生物材料（包括血液、組織和 DNA 樣本）在支持生物醫學研究方面發揮至關重要的作用。隨著全球對個人化醫療和基因組學的關注度不斷提高，對生物銀行服務的需求預計將上升，使該市場實現強勁擴張。

此外，生物銀行技術的進步正在推動市場創新。自動化樣品處理、儲存解決方案和資料管理系統的發展正在提高生物庫的效率和可靠性。這些創新不僅提高了樣本的完整性和可訪問性，而且促進了生物庫與高通量測序和生物資訊學等先進研究方法的結合。隨著研究不斷探索生物銀行的新應用，在改善研究成果和合作的推動下，市場可能會進一步擴大。

此外，對道德考慮和法規遵從性的日益重視正在塑造生物銀行的格局。隨著生物庫在樣本收集和使用方面遵守複雜的道德框架和法規，對透明和合規的生物庫實踐的需求可能會增加。這一趨勢在患者同意和資料隱私的背景下尤其重要，因為保持信任和透明度至關重要。隨著生物銀行市場不斷發展，技術進步、道德考量和合作重點的結合將在塑造其未來發展軌跡方面發揮關鍵作用。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

目錄

第 1 章：前言

  • 報告描述
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究流程
    • 市場研究方法

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：生物銀行產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按產品和服務進行市場吸引力分析
    • 依樣品類型進行市場吸引力分析
    • 按儲存類型進行市場吸引力分析
    • 按所有權分類的市場吸引力分析
    • 市場吸引力分析：按應用
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第4章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球生物銀行市場分析：按產品和服務

  • 產品和服務概覽
  • 按產品和服務進行的歷史和預測數據分析
  • 設備（儲存設備、樣品分析設備、樣品處理設備、樣品運輸設備）
  • 耗材（儲存耗材、分析耗材、處理耗材、收集耗材）
  • 服務
  • 軟體

第 6 章：全球生物銀行市場分析：依樣本類型

  • 樣品類型概覽
  • 按樣本類型進行的歷史和預測資料分析
  • 血液製品
  • 人體組織
  • 細胞系
  • 核酸
  • 生物體液
  • 人類廢物

第 7 章：全球生物銀行市場分析：按儲存類型

  • 依儲存類型概覽
  • 按儲存類型進行的歷史和預測資料分析
  • 手動儲存
  • 自動化存儲

第 8 章：全球生物銀行市場分析：按所有權分類

  • 所有權概覽
  • 按所有權進行歷史和預測資料分析
  • 大學
  • 國家/地區代理機構
  • 非營利組織
  • 私人組織

第 9 章：全球生物銀行市場分析：按應用

  • 概述：按應用
  • 歷史和預測數據分析：按應用
  • 再生醫學
  • 生命科學研究
  • 臨床研究

第 10 章：全球生物銀行市場分析：按最終用戶

  • 最終用戶概覽
  • 最終用戶的歷史和預測數據分析
  • 製藥和生物技術公司及 CRO
  • 學術及研究機構
  • 醫院

第 11 章：全球生物銀行市場分析：按地區分類

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美各細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲各細分市場銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區分部銷售分析
    • 亞太地區國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東和非洲分部銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第 12 章：生物銀行公司的競爭格局

  • 生物銀行市場競爭
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品發布
  • 其他進展

第 13 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Merck KGaA
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Thermo Fisher Scientific Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Becton
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Dickinson And Company
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • PHC Holdings Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Avantor Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Greiner Holding AG
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Azenta Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Tecan Trading AG
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Hamilton Company
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cryoport Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Micronic
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • AMSBIO
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bay Biosciences LLC
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BioKryo
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • SPT Labtech
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

Product Code: VMR11212372

Global Biobanking Market size is anticipated to grow from USD 3.84 Billion in 2024 to USD 10.73 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 12.07% during the forecast period of 2026 to 2033.

The biobanking market is poised for significant growth, driven by the increasing demand for biological samples and data for research and clinical applications. Biobanks play a crucial role in supporting biomedical research by providing access to a wide range of biological materials, including blood, tissue, and DNA samples. As the global focus on personalized medicine and genomics intensifies, the demand for biobanking services is expected to rise, positioning this market for robust expansion.

Moreover, advancements in biobanking technologies are driving innovation within the market. The development of automated sample processing, storage solutions, and data management systems is enhancing the efficiency and reliability of biobanks. These innovations not only improve sample integrity and accessibility but also facilitate the integration of biobanking with advanced research methodologies, such as high-throughput sequencing and bioinformatics. As research continues to explore new applications for biobanking, the market is likely to expand further, driven by the promise of improved research outcomes and collaboration.

Additionally, the growing emphasis on ethical considerations and regulatory compliance is shaping the biobanking landscape. As biobanks navigate complex ethical frameworks and regulations regarding sample collection and usage, the demand for transparent and compliant biobanking practices is likely to increase. This trend is particularly relevant in the context of patient consent and data privacy, where maintaining trust and transparency is essential. As the biobanking market continues to evolve, the combination of technological advancements, ethical considerations, and a focus on collaboration will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product &Service

  • Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment)
  • Consumables (Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables)
  • Services
  • Software

By Sample Type

  • Blood Products
  • Human Tissues
  • Cell Lines
  • Nucleic Acids
  • Biological Fluids
  • Human Waste Products

By Storage Type

  • Manual Storage
  • Automated Storage

By Ownership

  • Universities
  • National/Regional Agencies
  • Non-Profit Organizations
  • Private Organizations

By Application

  • Regenerative Medicine
  • Life Science Research
  • Clinical Research

By End user

  • Pharmaceutical & Biotechnology Companies and CROs
  • Academic & Research Institutes
  • Hospitals
  • COMPANIES PROFILED
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Becton
  • Dickinson and Company
  • PHC Holdings Corporation
  • Avantor Inc.
  • Greiner Holding AG
  • Azenta Inc.
  • Tecan Trading AG
  • Hamilton Company
  • Cryoport Inc.
  • Micronic
  • AMSBIO
  • Bay Biosciences LLC
  • BioKryo
  • SPT Labtech
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. BIOBANKING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product &Service
    • 3.7.2 Market Attractiveness Analysis By Sample Type
    • 3.7.3 Market Attractiveness Analysis By Storage Type
    • 3.7.4 Market Attractiveness Analysis By Ownership
    • 3.7.5 Market Attractiveness Analysis By Application
    • 3.7.6 Market Attractiveness Analysis By End user
    • 3.7.7 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOBANKING MARKET ANALYSIS BY PRODUCT &SERVICE

  • 5.1. Overview By Product &Service
  • 5.2. Historical and Forecast Data Analysis By Product &Service
  • 5.3. Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment) Historic and Forecast Sales By Regions
  • 5.4. Consumables (Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables) Historic and Forecast Sales By Regions
  • 5.5. Services Historic and Forecast Sales By Regions
  • 5.6. Software Historic and Forecast Sales By Regions

6. GLOBAL BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE

  • 6.1. Overview By Sample Type
  • 6.2. Historical and Forecast Data Analysis By Sample Type
  • 6.3. Blood Products Historic and Forecast Sales By Regions
  • 6.4. Human Tissues Historic and Forecast Sales By Regions
  • 6.5. Cell Lines Historic and Forecast Sales By Regions
  • 6.6. Nucleic Acids Historic and Forecast Sales By Regions
  • 6.7. Biological Fluids Historic and Forecast Sales By Regions
  • 6.8. Human Waste Products Historic and Forecast Sales By Regions

7. GLOBAL BIOBANKING MARKET ANALYSIS BY STORAGE TYPE

  • 7.1. Overview By Storage Type
  • 7.2. Historical and Forecast Data Analysis By Storage Type
  • 7.3. Manual Storage Historic and Forecast Sales By Regions
  • 7.4. Automated Storage Historic and Forecast Sales By Regions

8. GLOBAL BIOBANKING MARKET ANALYSIS BY OWNERSHIP

  • 8.1. Overview By Ownership
  • 8.2. Historical and Forecast Data Analysis By Ownership
  • 8.3. Universities Historic and Forecast Sales By Regions
  • 8.4. National/Regional Agencies Historic and Forecast Sales By Regions
  • 8.5. Non-Profit Organizations Historic and Forecast Sales By Regions
  • 8.6. Private Organizations Historic and Forecast Sales By Regions

9. GLOBAL BIOBANKING MARKET ANALYSIS BY APPLICATION

  • 9.1. Overview By Application
  • 9.2. Historical and Forecast Data Analysis By Application
  • 9.3. Regenerative Medicine Historic and Forecast Sales By Regions
  • 9.4. Life Science Research Historic and Forecast Sales By Regions
  • 9.5. Clinical Research Historic and Forecast Sales By Regions

10. GLOBAL BIOBANKING MARKET ANALYSIS BY END USER

  • 10.1. Overview By End user
  • 10.2. Historical and Forecast Data Analysis By End user
  • 10.3. Pharmaceutical & Biotechnology Companies and CROs Historic and Forecast Sales By Regions
  • 10.4. Academic & Research Institutes Historic and Forecast Sales By Regions
  • 10.5. Hospitals Historic and Forecast Sales By Regions

11. GLOBAL BIOBANKING MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Regional Outlook
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.3.2 North America By Segment Sales Analysis
    • 11.3.3 North America By Country Sales Analysis
    • 11.3.4 United States Sales Analysis
    • 11.3.5 Canada Sales Analysis
    • 11.3.6 Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.4.2 Europe By Segment Sales Analysis
    • 11.4.3 Europe By Country Sales Analysis
    • 11.4.4 United Kingdom Sales Analysis
    • 11.4.5 France Sales Analysis
    • 11.4.6 Germany Sales Analysis
    • 11.4.7 Italy Sales Analysis
    • 11.4.8 Russia Sales Analysis
    • 11.4.9 Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.5.2 Asia Pacific By Segment Sales Analysis
    • 11.5.3 Asia Pacific By Country Sales Analysis
    • 11.5.4 China Sales Analysis
    • 11.5.5 India Sales Analysis
    • 11.5.6 Japan Sales Analysis
    • 11.5.7 South Korea Sales Analysis
    • 11.5.8 Australia Sales Analysis
    • 11.5.9 South East Asia Sales Analysis
    • 11.5.10 Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.6.2 Latin America By Segment Sales Analysis
    • 11.6.3 Latin America By Country Sales Analysis
    • 11.6.4 Brazil Sales Analysis
    • 11.6.5 Argentina Sales Analysis
    • 11.6.6 Peru Sales Analysis
    • 11.6.7 Chile Sales Analysis
    • 11.6.8 Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.7.2 Middle East & Africa By Segment Sales Analysis
    • 11.7.3 Middle East & Africa By Country Sales Analysis
    • 11.7.4 Saudi Arabia Sales Analysis
    • 11.7.5 UAE Sales Analysis
    • 11.7.6 Israel Sales Analysis
    • 11.7.7 South Africa Sales Analysis
    • 11.7.8 Rest Of Middle East And Africa Sales Analysis

12. COMPETITIVE LANDSCAPE OF THE BIOBANKING COMPANIES

  • 12.1. Biobanking Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13. COMPANY PROFILES OF BIOBANKING INDUSTRY

  • 13.1. Top Companies Market Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Merck KGaA
    • 13.3.1 Company Overview
    • 13.3.2 Company Revenue
    • 13.3.3 Products
    • 13.3.4 Recent Developments
  • 13.4. Thermo Fisher Scientific Inc.
    • 13.4.1 Company Overview
    • 13.4.2 Company Revenue
    • 13.4.3 Products
    • 13.4.4 Recent Developments
  • 13.5. Becton
    • 13.5.1 Company Overview
    • 13.5.2 Company Revenue
    • 13.5.3 Products
    • 13.5.4 Recent Developments
  • 13.6. Dickinson And Company
    • 13.6.1 Company Overview
    • 13.6.2 Company Revenue
    • 13.6.3 Products
    • 13.6.4 Recent Developments
  • 13.7. PHC Holdings Corporation
    • 13.7.1 Company Overview
    • 13.7.2 Company Revenue
    • 13.7.3 Products
    • 13.7.4 Recent Developments
  • 13.8. Avantor Inc.
    • 13.8.1 Company Overview
    • 13.8.2 Company Revenue
    • 13.8.3 Products
    • 13.8.4 Recent Developments
  • 13.9. Greiner Holding AG
    • 13.9.1 Company Overview
    • 13.9.2 Company Revenue
    • 13.9.3 Products
    • 13.9.4 Recent Developments
  • 13.10. Azenta Inc.
    • 13.10.1 Company Overview
    • 13.10.2 Company Revenue
    • 13.10.3 Products
    • 13.10.4 Recent Developments
  • 13.11. Tecan Trading AG
    • 13.11.1 Company Overview
    • 13.11.2 Company Revenue
    • 13.11.3 Products
    • 13.11.4 Recent Developments
  • 13.12. Hamilton Company
    • 13.12.1 Company Overview
    • 13.12.2 Company Revenue
    • 13.12.3 Products
    • 13.12.4 Recent Developments
  • 13.13. Cryoport Inc.
    • 13.13.1 Company Overview
    • 13.13.2 Company Revenue
    • 13.13.3 Products
    • 13.13.4 Recent Developments
  • 13.14. Micronic
    • 13.14.1 Company Overview
    • 13.14.2 Company Revenue
    • 13.14.3 Products
    • 13.14.4 Recent Developments
  • 13.15. AMSBIO
    • 13.15.1 Company Overview
    • 13.15.2 Company Revenue
    • 13.15.3 Products
    • 13.15.4 Recent Developments
  • 13.16. Bay Biosciences LLC
    • 13.16.1 Company Overview
    • 13.16.2 Company Revenue
    • 13.16.3 Products
    • 13.16.4 Recent Developments
  • 13.17. BioKryo
    • 13.17.1 Company Overview
    • 13.17.2 Company Revenue
    • 13.17.3 Products
    • 13.17.4 Recent Developments
  • 13.18. SPT Labtech
    • 13.18.1 Company Overview
    • 13.18.2 Company Revenue
    • 13.18.3 Products
    • 13.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product &Service (USD MN)
  • Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment) Market Sales By Geography (USD MN)
  • Consumables (Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables) Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Analysis By Sample Type (USD MN)
  • Blood Products Market Sales By Geography (USD MN)
  • Human Tissues Market Sales By Geography (USD MN)
  • Cell Lines Market Sales By Geography (USD MN)
  • Nucleic Acids Market Sales By Geography (USD MN)
  • Biological Fluids Market Sales By Geography (USD MN)
  • Human Waste Products Market Sales By Geography (USD MN)
  • Analysis By Storage Type (USD MN)
  • Manual Storage Market Sales By Geography (USD MN)
  • Automated Storage Market Sales By Geography (USD MN)
  • Analysis By Ownership (USD MN)
  • Universities Market Sales By Geography (USD MN)
  • National/Regional Agencies Market Sales By Geography (USD MN)
  • Non-Profit Organizations Market Sales By Geography (USD MN)
  • Private Organizations Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Regenerative Medicine Market Sales By Geography (USD MN)
  • Life Science Research Market Sales By Geography (USD MN)
  • Clinical Research Market Sales By Geography (USD MN)
  • Analysis By End user (USD MN)
  • Pharmaceutical & Biotechnology Companies and CROs Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Global Biobanking Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Biobanking Report
  • Market Research Process
  • Market Research Methodology
  • Global Biobanking Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product &Service
  • Market Attractiveness Analysis By Sample Type
  • Market Attractiveness Analysis By Storage Type
  • Market Attractiveness Analysis By Ownership
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End user
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product &Service (USD MN)
  • Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment) Market Sales By Geography (USD MN)
  • Consumables (Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables) Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Global Market Analysis By Sample Type (USD MN)
  • Blood Products Market Sales By Geography (USD MN)
  • Human Tissues Market Sales By Geography (USD MN)
  • Cell Lines Market Sales By Geography (USD MN)
  • Nucleic Acids Market Sales By Geography (USD MN)
  • Biological Fluids Market Sales By Geography (USD MN)
  • Human Waste Products Market Sales By Geography (USD MN)
  • Global Market Analysis By Storage Type (USD MN)
  • Manual Storage Market Sales By Geography (USD MN)
  • Automated Storage Market Sales By Geography (USD MN)
  • Global Market Analysis By Ownership (USD MN)
  • Universities Market Sales By Geography (USD MN)
  • National/Regional Agencies Market Sales By Geography (USD MN)
  • Non-Profit Organizations Market Sales By Geography (USD MN)
  • Private Organizations Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Regenerative Medicine Market Sales By Geography (USD MN)
  • Life Science Research Market Sales By Geography (USD MN)
  • Clinical Research Market Sales By Geography (USD MN)
  • Global Market Analysis By End user (USD MN)
  • Pharmaceutical & Biotechnology Companies and CROs Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.